Deutsche Bank Aktiengesellschaft Issues Positive Forecast for KKR & Co. Inc. (NYSE:KKR) Stock Price

KKR & Co. Inc. (NYSE:KKR) had its price objective raised by Deutsche Bank Aktiengesellschaft from $158.00 to $159.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have a buy rating on the asset manager’s stock.

Several other brokerages have also recently issued reports on KKR. Oppenheimer boosted their price objective on shares of KKR & Co. Inc. from $128.00 to $148.00 and gave the company an “outperform” rating in a research note on Wednesday, October 16th. Citigroup boosted their price objective on shares of KKR & Co. Inc. from $157.00 to $171.00 and gave the company a “buy” rating in a research note on Friday, October 25th. Evercore ISI boosted their price objective on shares of KKR & Co. Inc. from $135.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. HSBC started coverage on shares of KKR & Co. Inc. in a research note on Wednesday, September 18th. They issued a “buy” rating and a $148.00 price objective on the stock. Finally, StockNews.com raised shares of KKR & Co. Inc. to a “sell” rating in a research note on Friday, October 25th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $152.93.

KKR & Co. Inc. Stock Performance

Shares of KKR & Co. Inc. stock opened at $155.93 on Monday. The firm’s fifty day simple moving average is $132.81 and its 200-day simple moving average is $117.49. The stock has a market capitalization of $138.50 billion, a price-to-earnings ratio of 47.40, a PEG ratio of 1.23 and a beta of 1.61. KKR & Co. Inc. has a 12 month low of $62.92 and a 12 month high of $156.54. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07.

KKR & Co. Inc. (NYSE:KKR) last announced its earnings results on Thursday, October 24th. The asset manager reported $1.38 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.35. The business had revenue of $4.79 billion for the quarter, compared to analysts’ expectations of $1.23 billion. KKR & Co. Inc. had a net margin of 13.21% and a return on equity of 5.77%. During the same period in the previous year, the company posted $0.73 EPS. As a group, equities analysts forecast that KKR & Co. Inc. will post 4.12 earnings per share for the current year.

KKR & Co. Inc. Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 19th. Shareholders of record on Monday, November 4th will be issued a $0.175 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $0.70 dividend on an annualized basis and a yield of 0.45%. KKR & Co. Inc.’s dividend payout ratio (DPR) is 21.28%.

Insider Buying and Selling at KKR & Co. Inc.

In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the transaction, the insider now owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In related news, major shareholder Kkr Group Partnership L.P. acquired 11,619,998 shares of the company’s stock in a transaction dated Wednesday, September 11th. The stock was bought at an average price of $11.13 per share, with a total value of $129,330,577.74. Following the purchase, the insider now directly owns 92,959,984 shares in the company, valued at $1,034,644,621.92. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the transaction, the insider now directly owns 25,260,971 shares of the company’s stock, valued at approximately $650,470,003.25. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 39.34% of the stock is owned by insiders.

Institutional Trading of KKR & Co. Inc.

A number of institutional investors and hedge funds have recently bought and sold shares of KKR. Versant Capital Management Inc increased its position in KKR & Co. Inc. by 622.9% during the 2nd quarter. Versant Capital Management Inc now owns 253 shares of the asset manager’s stock worth $27,000 after purchasing an additional 218 shares in the last quarter. Mather Group LLC. increased its position in KKR & Co. Inc. by 371.4% during the 2nd quarter. Mather Group LLC. now owns 264 shares of the asset manager’s stock worth $27,000 after purchasing an additional 208 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in KKR & Co. Inc. during the 3rd quarter worth approximately $31,000. Raleigh Capital Management Inc. increased its position in KKR & Co. Inc. by 56.7% during the 3rd quarter. Raleigh Capital Management Inc. now owns 235 shares of the asset manager’s stock worth $31,000 after purchasing an additional 85 shares in the last quarter. Finally, Eastern Bank acquired a new stake in KKR & Co. Inc. during the 3rd quarter worth approximately $34,000. Institutional investors and hedge funds own 76.26% of the company’s stock.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.